Completed PHASE1 INTERVENTIONAL 5-arm NCT06766864

A Study of Subcutaneous DR-01 in Healthy Volunteers

A Randomized, Double-blind, Placebo-controlled, Phase 1 Study Evaluating the Safety and Pharmacokinetics of Subcutaneous Administration of Single Ascending Doses of DR-01 in Healthy Volunteers

Sponsor: Dren Bio

Conditions Healthy Volunteer

Interventions DR-01 Placebo

Updated 6 times since 2025 Last updated: Sep 26, 2025 Started: Mar 3, 2025 Primary completion: Aug 27, 2025 Completion: Aug 27, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy Volunteer, this trial is completed. The trial is conducted by Dren Bio and has accumulated 6 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Oct 2025 — Present [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Sep 2025 — Oct 2025 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting
Aug 2025 — Sep 2025 [monthly]

Recruiting PHASE1
Apr 2025 — Aug 2025 [monthly]

Recruiting PHASE1
Mar 2025 — Apr 2025 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Feb 2025 — Mar 2025 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dren Bio

Data source: Dren Bio

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Auckland, New Zealand